tiprankstipranks
Trending News
More News >
Insmed (INSM)
NASDAQ:INSM
US Market
Advertisement

Insmed (INSM) Technical Analysis

Compare
985 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Insmed’s (INSM) Moving Averages Convergence Divergence (MACD) indicator is 5.92, suggesting Insmed is a Sell.
Insmed’s (INSM) 20-Day exponential moving average is 146.83, while Insmed’s (INSM) share price is $162.32, making it a Buy.
Insmed’s (INSM) 50-Day exponential moving average is 134.61, while Insmed’s (INSM) share price is $162.32, making it a Buy.

Insmed (INSM) Pivot Points

Oct 08, 2025, 04:51 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
152.90
154.91
156.60
158.61
160.29
162.30
163.99
Fibonacci
154.91
156.32
157.20
158.61
160.02
160.89
162.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Insmed (INSM) Moving Averages

Oct 08, 2025, 04:51 PM
Period
Simple
Exponential
MA5
155.57Buy
155.99Buy
MA10
147.71Buy
151.44Buy
MA20
146.42Buy
146.83Buy
MA50
134.11Buy
134.61Buy
MA100
112.05Buy
118.69Buy
MA200
92.89Buy
100.45Buy
Insmed’s (INSM) 10-Day exponential moving average is 151.44, while Insmed’s (INSM) share price is $162.32, making it a Buy.
Insmed’s (INSM) 100-Day exponential moving average is 118.69, while Insmed’s (INSM) share price is $162.32, making it a Buy.
Insmed’s (INSM) stock price is $162.32 and Insmed’s (INSM) 50-day simple moving average is 134.11, creating a Buy signal.
Insmed’s (INSM) stock price is $162.32 and Insmed’s (INSM) 100-day simple moving average is 112.05, creating a Buy signal.
Insmed’s (INSM) stock price is $162.32 and Insmed’s (INSM) 200-day simple moving average is 92.89, creating a Buy signal.

Insmed (INSM) Technical Indicators

Oct 08, 2025, 04:51 PM
Name
Value
Implied Action
RSI (14)
77.37
Sell
STOCH (9,6)
95.51
Sell
STOCHRSI (14)
95.51
Sell
MACD (12,26)
5.92
Sell
ADX (14)
37.50
Neutral
Williams %R
-0.42
Sell
CCI (14)
234.28
Sell
ATR (14)
4.47
-
Ultimate Oscillator
76.50
Buy
ROC
12.11
Buy
Insmed’s (INSM) Relative Strength Index (RSI) is 77.37, creating a Sell signal.
Insmed’s (INSM) Trend Strength Indicator (ADX) is 37.50, creating a Neutral signal.
Insmed’s (INSM) Commodity Channel Index (CCI) is 234.28, creating a Sell signal.
Insmed’s (INSM) Price Rate of Change (ROC) is 12.11, creating a Buy signal.

FAQ

Is INSM a Buy, Hold, or Sell?
Based on INSM’s technical indicators, INSM is a Buy.
    What is INSM’s RSI (14)?
    INSM’s RSI (14) is 77.37, which suggests INSM is a Sell.
      What is INSM’s MACD?
      INSM’s MACD is 5.92, which suggests INSM is a Sell.
        What is INSM’s 5-day moving average?
        INSM’s 5-day moving average is 155.57, which suggests INSM is a Buy.
          What is INSM’s 20-day moving average?
          INSM 20-day moving average is 146.42, which suggests INSM is a Buy.
            What is INSM’s 50-day moving average?
            INSM’s 50-day moving average is 134.11, which suggests INSM is a Buy.
              What is INSM’s 200-day moving average?
              INSM’s 200-day moving average is 92.89, which suggests INSM is a Buy.
                What is INSM’s Williams % R (14)?
                INSM’s Williams % R (14) is -0.42, which suggests INSM is a Sell.
                  What is INSM’s CCI (14)?
                  INSM’s CCI (14) is 234.28, which suggests INSM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis